Nuvelo (Nasdaq: NUVO) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nuvelo (Nasdaq: NUVO)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Edscharp who wrote (89)	1/28/2000 11:20:00 AM
From: nigel bates	Read Replies (1) of 286

>>Interesting Chart<< It depends upon when you start - siliconinvestor.com I was more interested by this - biz.yahoo.com - ``Biochip designs that require a reference sequence, including those that do SNP analysis, may need to secure rights in the reference sequence. The advanced technology Hyseq uses to determine the sequence of any DNA sample may allow our biochips to detect polymorphisms or mutations in patient samples without using gene sequences that may be owned by others, thereby avoiding this pitfall,'" Wonder how much uncertainty is implied by the 'may'. nig

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next